prison

Publication cover
Document library

Prisons and Health

14.08.2014
This book outlines important suggestions by international experts to improve the health of those in prison and to reduce both the health risks and risks to society of imprisonment. In particular, it...
document cover
Document library

Final minutes of Drug and Prison European meeting, 22-23 October 2012

28.01.2013
Minutes from the Drug and Prison European meeting hosted by the EMCDDA in Lisbon, 22-23 October 2012.
document cover
Document library

Minutes of Drug and Prison European meeting, 30-31 May 2013

11.03.2014
Minutes from the Drug and Prison European meeting hosted by the EMCDDA in Lisbon, 30-31 May 2013
Last updated : 05.12.2019
Rating: Likely to be beneficial

Pre- and post -exposure prophylaxis of HIV (PrEP and PEP) were found in a systematic review (ECDC/EMCDDA, 2018) to be effective in:

  • reducing HIV transmission in prison

Name of response option

  • Pre- and post -exposure prophylaxis of HIV (PrEP and PEP)

Desired outcome(s)

  • reduce infectious diseases

Area(s)

  • Harm reduction

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Last updated : 05.12.2019
Rating: Beneficial

Health promotion and peer-education on blood borne viruses testing were found in a systematic review (ECDC/EMCDDA, 2018) to be effective in:

  • increasing blood borne viruses testing uptake in prison

Name of response option

  • Health promotion and peer-education on blood borne viruses testing

Desired outcome(s)

  • reduce infectious diseases

Area(s)

  • Harm reduction

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Last updated : 05.12.2019
Rating: Beneficial

HBV, HCV and HIV testing upon admission and to all people in prison was found in a systematic review (ECDC/EMCDDA, 2018) to be effective in:

  • reducing HIV transmission.

The evidence suggests that provider-initiated strategies for HIV testing yield a higher uptake than prisoner-initiated strategies.

Name of response option

  • HBV, HCV and HIV testing upon admission in prison

Desired outcome(s)

  • reduce infectious diseases

Area(s)

  • Harm reduction

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Last updated : 05.12.2019
Rating: Beneficial

Provision of HBV vaccination with unknown or negative serology was found in a systematic review (ECDC/EMCDDA, 2018) to be effective in:

  • reducing HBV transmission in prison

Name of response option

  • Provision of HBV vaccination in prison

Desired outcome(s)

  • reduce infectious diseases

Area(s)

  • Harm reduction

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Last updated : 05.12.2019
Rating: Beneficial

Provision of HBV, HCV and HIV treatment in prison was found in a systematic review (ECDC/EMCDDA, 2018) to be effective in:

  • reducing HBV, HCV and HIV transmission.

Name of response option

  • Provision of HBV, HCV and HIV treatment in prison

Desired outcome(s)

  • reduce infectious diseases

Area(s)

  • Treatment

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Last updated : 05.12.2019
Rating: Likely to be beneficial

Continuity of care between prison and community was found in a systematic review (ECDC/EMCDDA, 2018) to have some effect in:

  • improving retention in drug treatment, and
  • improving adherence to HIV and HCV treatment.

Name of response option

  • Continuity of treatment from prison to community

Desired outcome(s)

  • retain patients in treatment

Area(s)

  • Treatment

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Last updated : 05.12.2019
Rating: Likely to be beneficial

Provision of condoms and lubricant in prison was found in a systematic review (ECDC/EMCDDA, 2018) to have some effect in:

  • reducing sexual risk behaviours.

Name of response option

  • Provision of condoms and lubricant

Desired outcome(s)

  • reduce substance use

Area(s)

  • Harm reduction

Specific substance or pattern of use

not-drug specific

Target group(s) or setting(s)

prison

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.
Subscribe to prison
Top